NeuRizer Ltd (NRZ), an ASX-listed company, aims to be Australia's front runner manufacturer of urea fertilizer-the building block of crop production around the world.
| ASX Code | NRZ |
| Website | http://www.neurizer.com.au |
| Industry/Sector | Fertilizers & Agricultural Chemicals |
| Market Cap ($M) | 3 |
| NRZ Share Price | $0.001 |
| Day High | $0.002 |
| Day Low | $0.001 |
| Last Close | $0.001 |
| NRZ Share Price Movement | - ( No change ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from NeuRizer Ltd (NRZ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2024A | -$5.60 | -$0.40 | -76.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$17.25 | -$1.70 | -32.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$20.40 | -$2.50 | 20.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2022 A | 2023 A | 2024 A | 2022 A | 2023 A | 2024 A | 2022 A | 2023 A | 2024 A | ||
| NeuRizer Ltd (NRZ) | $3M | -0.7665 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Nufarm Limited (NUF) | $1,049M | 1.6328 | -0.2518 | 1.1579 | 22.3954 | 29.9342 | 13.8720 | 0.00% | 0.00% | 2.16% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.03 | 0.00 |
| Market | 0.28 | 13.00 | 1.15 | 0.59 |
| Sector | 1.71 | 14.10 | 1.62 | 0.22 |
| Name | Position | Start Date |
|---|---|---|
| Mr Daniel Justyn Douglas Peters | Executive Chairman, Executive Director, Company Secretary | 28 Nov 2014 |
| Mr Zhe Wang | Non-Executive Director | 1 Jul 2017 |
| Mr Xiaojiang Zheng | Non-Executive Director | 5 Dec 2017 |
| Mr Manyoo Han | Non-Executive Director | 17 May 2024 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 7 Dec 2023 | WANG, Zhe | Issued | Direct Shares | 14,285,714 | $0.070 | $999,999.980 |
| 1 Jun 2023 | STAVELEY, Phillip (Phil) | Sell | Indirect Shares | 2,000,000 | $0.097 | $194,200.000 |
| 4 Mar 2022 | STAVELEY, Phillip (Phil) | Buy | Indirect Shares | 133,334 | $0.150 | $20,000.100 |
See all changes in directors' interest & trades for NeuRizer Ltd (NRZ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in NeuRizer Ltd (NRZ). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 144,777,186 (6.64%) | Citicorp Nominees Pty Limited |
| 137,653,334 (6.31%) | China New Energy Group Limited |
| Date | Event |
|---|---|
| 03 May 2027 | Report (Quarterly) |
| 30 March 2027 | Report (Quarterly) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.